Pharmafile Logo

Press release: InSite Event™ named one of the most innovative services of 2020

Press Release

Contact: Jess Masciangelo, Business Development Director
jmasciangelo@impetusdigital.com
meetwithimpetus.com

INSITE EVENT™ NAMED ONE OF THE MOST INNOVATIVE SERVICES OF 2020

Toronto, ON, December 10, 2020 — Impetus Digital’s new virtual event platform InSite Event™ has been named as one of the most innovative services of 2020.

InSite Event™ is a GDPR- and HIPAA-compliant, “all-in-one,” completely customizable virtual event solution, ideal for medical congresses, conferences, education events, and corporate meetings. InSite Event™ is made to resemble and include all aspects of in-person events. Participants can move seamlessly between sessions and engage in live audience Q&A, breakout sessions, networking, and more. Networking can leverage intelligent matching, be pre-scheduled or on-demand, synchronous or asynchronous, and only for those who opt-in, ensuring high levels of engagement and privacy.

Attendees can also visit exhibitor booths, poster presentations, and connect with sponsors, speakers, and other participants using a variety of fun and engaging quizzes, competitions, and games before, during, and after the event. To monitor the success of the event, organizers have real-time access to several key user metrics.

“The pandemic has precipitated the reimagining of in-person events and we are thrilled to be pioneers in the virtual event space for life science companies,” says Natalie Yeadon, Co-founder and CEO of Impetus Digital. “Our all-in-one platform is revolutionary, as many companies have to leverage multiple platforms, which can be confusing, arduous, and expensive to manage,” she explains. “We look forward to continuing to leverage the enormous appetite for virtual event platforms like InSite Event™”

Read the full statement here.

This content was provided by Impetus Digital

Company Details

 Latest Content from  Impetus Digital 

There’s No Going Back: How COVID-19 will Change Pharma Forever

Munther Baara, VP Product Strategy and Innovation at EDETEK, discusses all things clinical trials. Especially, we discuss the current gaps and the impact of COVID-19 on the way Pharma approaches...

Powering Rapid Cognitive Analysis with AI

Dr. Tom Sawyer, CFO at Cognetivity Neurosciences, discusses the benefits of AI-driven dementia detection technology for patients, health care providers, and clinical research.

KOL Ambassador Program & Podcast Creation: A Customer Story

Leveraging Impetus Digital’s best-in-class synchronous (real-time) and asynchronous (over-time, anytime) tools, our client facilitated a virtual ambassador program with three oncologist key opinion leaders (KOLs) from South Korea.The client’s main objectives...

Importance of Emotional Intelligence in Pharma and Medical Affairs

Emma Lynch, Founder of EQ Vibration & Quadrant 2 Medical, explores a number of interesting topics related to Medical Affairs. Among many other things, she discusses the importance of emotional...

Virtual product launch planning: the ultimate playbook

We walk you through, step-by-step, how cross-functional teams can seamlessly work together and overcome the many obstacles associated with traditional product launches.

Artificial Intelligence for Identifying and Monitoring Cognitive Decline

Liam Kaufman, CEO & Co-founder of Winterlight Labs, explores a range of topics related to AI, machine learning, natural language processing, digital biomarkers, and human-computer interactions in healthcare.

Trust and transparency in Pharma & healthcare: impact of the COVID-19 pandemic

While it is obvious that trust in life science and healthcare companies is suboptimal, exactly how to improve the public’s trust is unclear...

Navigating the Nuances of Europe’s MedTech Industry

Richard Houlihan, CEO of EirMed, explores topics related to EUDAMED, the European Databank for Medical Devices, including the key pain points and concerns MedTech companies encounter related to EUDAMED and...

Pharma, Technology, and Healthcare in the New Normal

Brian Canestraro, General Manager at Intercept Pharmaceuticals, discusses leadership lessons and tips to the impact of the COVID-19 pandemic on the way that Pharma conducts clinical trials and interacts with...